Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neuronopathy, Distal Hereditary Motor, Type IIB 1Neoplasms 1

Interventions

vocimagene amiretrorepvec 1enfortumab vedotin 1catumaxomab 1apatorsen 1Ty21a typhoid vaccine 1Therapeutics 1Photochemotherapy 1Paclitaxel 1Mitomycin 1Imiquimod 1Gemcitabine 1Flucytosine 1Ethacrynic Acid 1Bevacizumab 1BCG Vaccine 1Antibodies 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Non-Muscle Invasive Bladder Neoplasms × apatorsen × Clear all
NCT00959868 2012-02-13

A Study for Treatment of Superficial Bladder Cancer Using OGX-427

Vancouver Coastal Health

Phase 1 Unknown
36 enrolled
Genitourinary

Neuronopathy, Distal Hereditary Motor, Type IIB, Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡